Related Experiment Video
Updated: Jun 17, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Pyroptosis leads to loss of centrosomal integrity in macrophages
Siyi Bai1,2, Fatima Martin-Sanchez1,2,3,4, David Brough2,5,6
1Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PT, UK.
Abstract:
NLRP3 forms a multiprotein inflammasome complex to initiate the inflammatory response when macrophages sense infection or tissue damage, which leads to caspase-1 activation, maturation and release of the inflammatory cytokines interleukin-1β (IL-1β) and IL-18 and Gasdermin-D (GSDMD) mediated pyroptosis. NLRP3 inflammasome activity must be controlled as unregulated and chronic inflammation underlies inflammatory and autoimmune diseases. Several findings uncovered that NLRP3 inflammasome activity is under the regulation of centrosome localized proteins such as NEK7 and HDAC6, however, whether the centrosome composition or structure is altered during the inflammasome activation is not known. Our data show that levels of the centrosomal scaffold protein pericentrin (PCNT) are reduced upon NLRP3 inflammasome activation via different activators in human and murine macrophages. PCNT loss occurs in the presence of membrane stabilizer punicalagin, suggesting this is not a consequence of membrane rupture. We found that PCNT loss is dependent on NLRP3 and active caspases as MCC950 and pan caspase inhibitor ZVAD prevent its degradation. Moreover, caspase-1 and GSDMD are both required for this NLRP3-mediated PCNT loss because absence of caspase-1 or GSDMD triggers an alternative regulation of PCNT via its cleavage by caspase-3 in response to nigericin stimulation. PCNT degradation occurs in response to nigericin, but also other NLRP3 activators including lysomotropic agent L-Leucyl-L-Leucine methyl ester (LLOMe) and hypotonicity but not AIM2 activation. Our work reveals that the NLRP3 inflammasome activation alters centrosome composition highlighting the need to further understand the role of this organelle during inflammatory responses.
Insights
NLRP3 inflammasome activation reduces pericentrin (PCNT) levels in macrophages. This degradation is caspase-dependent and highlights altered centrosome composition during inflammation.
Area of Science:
- Immunology
- Cell Biology
Background:
- The NLRP3 inflammasome initiates inflammatory responses, involving caspase-1 activation and cytokine release.
- Uncontrolled NLRP3 inflammasome activity contributes to inflammatory and autoimmune diseases.
- Centrosomal proteins regulate NLRP3 inflammasome activity, but centrosome structural changes during activation are unknown.
Purpose of the Study:
- To investigate whether NLRP3 inflammasome activation alters centrosome composition.
- To identify changes in centrosomal proteins during inflammasome activation.
Main Methods:
- Human and murine macrophages were stimulated with NLRP3 activators.
- Pericentrin (PCNT) levels were assessed via Western blotting.
- The role of caspases and Gasdermin-D (GSDMD) in PCNT degradation was examined using inhibitors and knockout models.
Main Results:
- NLRP3 inflammasome activation led to reduced pericentrin (PCNT) levels in macrophages.
- PCNT loss was dependent on NLRP3 and active caspases, and required caspase-1 and GSDMD.
- In the absence of caspase-1 or GSDMD, PCNT was cleaved by caspase-3.
Conclusions:
- NLRP3 inflammasome activation alters centrosome composition by reducing PCNT levels.
- This centrosomal protein alteration is mediated by caspases and GSDMD.
- Further research is needed to understand the role of the centrosome in inflammatory responses.

